Angiodynamics (ANGO) EBIAT (2016 - 2025)
Historic EBIAT for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to -$6.4 million.
- Angiodynamics' EBIAT rose 4086.42% to -$6.4 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$27.7 million, marking a year-over-year increase of 8766.92%. This contributed to the annual value of -$34.0 million for FY2025, which is 8156.05% up from last year.
- As of Q4 2025, Angiodynamics' EBIAT stood at -$6.4 million, which was up 4086.42% from -$10.9 million recorded in Q3 2025.
- Angiodynamics' EBIAT's 5-year high stood at $45.9 million during Q3 2023, with a 5-year trough of -$187.7 million in Q1 2024.
- For the 5-year period, Angiodynamics' EBIAT averaged around -$16.9 million, with its median value being -$9.0 million (2022).
- In the last 5 years, Angiodynamics' EBIAT surged by 45284.53% in 2023 and then plummeted by 187929.36% in 2024.
- Angiodynamics' EBIAT (Quarter) stood at -$8.4 million in 2021, then decreased by 1.62% to -$8.5 million in 2022, then crashed by 242.3% to -$29.0 million in 2023, then surged by 63.03% to -$10.7 million in 2024, then skyrocketed by 40.86% to -$6.4 million in 2025.
- Its last three reported values are -$6.4 million in Q4 2025, -$10.9 million for Q3 2025, and -$6.0 million during Q2 2025.